Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Corticosteroids for Prevention of HSV Keratitis Recurrence
NCT03626376Phase 4Withdrawn
- Sponsor
- NYU Langone Health
- Start
- Dec 2019
- Primary completion
- Mar 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of prednisolone in herpes simplex virus keratitis, sponsored by NYU Langone Health. Planned start Dec 2019; status: withdrawn.
02
Drugs
prednisolone
03
Conditions
herpes simplex virus keratitis
Beyond the preview
Go deeper on NCT03626376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03626376.